Abstract:Cancer cells use glucose and glutamine as the major sources of energy and precursor intermediates, and enhanced glycolysis and glutamimolysis are the major hallmarks of metabolic reprogramming in cancer. Oncogene activation and tumor suppressor gene inactivation alter multiple intracellular signaling pathways that affect glycolysis and glutaminolysis. N-Myc downstream regulated gene 2 (NDRG2) is a tumor suppressor gene inhibiting cancer growth, metastasis and invasion. However, the role and molecular mechanism of NDRG2 in cancer metabolism remains unclear. In this study, we discovered the role of the tumor suppressor gene NDRG2 in aerobic glycolysis and glutaminolysis of cancer cells. NDRG2 inhibited glucose consumption and lactate production, glutamine consumption and glutamate production in colorectal cancer cells. Analysis of glucose transporters and the catalytic enzymes involved in glycolysis revealed that glucose transporter 1 (GLUT1), hexokinase 2 (HK2), pyruvate kinase M2 isoform (PKM2) and lactate dehydrogenase A (LDHA) was significantly suppressed by NDRG2. Analysis of glutamine transporter and the catalytic enzymes involved in glutaminolysis revealed that glutamine transporter ASC amino-acid transporter 2 (ASCT2) and glutaminase 1 (GLS1) was also significantly suppressed by NDRG2. Transcription factor c-Myc mediated inhibition of glycolysis and glutaminolysis by NDRG2. More importantly, NDRG2 inhibited the expression of c-Myc by suppressing the expression of β-catenin, which can transcriptionally activate C-MYC gene in nucleus. In addition, the growth and proliferation of colorectal cancer cells were suppressed significantly by NDRG2 through inhibition of glycolysis and glutaminolysis. Taken together, these findings indicate that NDRG2 functions as an essential regulator in glycolysis and glutaminolysis via repression of c-Myc, and acts as a suppressor of carcinogenesis through coordinately targeting glucose and glutamine transporter, multiple catalytic enzymes involved in glycolysis and glutaminolysis, which fuels the bioenergy and biomaterials needed for cancer proliferation and progress.

Tumor Suppressor Candidate Gene, NDRG2 is Frequently Inactivated in Human Glioblastoma Multiforme

NDRG2 Expression and Mutation in Human Liver and Pancreatic Cancers

Promoter Methylation, Mutation, and Genomic Deletion Are Involved in the Decreased NDRG2 Expression Levels in Several Cancer Cell Lines.

N-Myc Downstream-Regulated Gene 2 (ndrg2) Inhibits Glioblastoma Cell Proliferation

N-Myc Downstream-Regulated Gene 2 (NDRG2) As a Novel Tumor Suppressor in Multiple Human Cancers

Promoter methylation status Promoter methylation status and expression of and expression of NDRG2 NDRG2 gene in gastric cardia gene in gastric cardia adenocarcinoma adenocarcinoma

Expression Pattern of NDR2 Gene, A Candidate Tumor-suppressor, in Different Human Tissues and Tumors

NDRG4 is Downregulated in Glioblastoma and Inhibits Cell Proliferation.

Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis.

Regulation of histone acetylation by NDRG2 in glioma cells

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Tumor Suppressor NDRG2 Inhibits Glycolysis and Glutaminolysis in Colorectal Cancer Cells by Repressing C-Myc Expression

N-myc Downstream-Regulated Gene 2 Expression is Associated with Glucose Transport and Correlated with Prognosis in Breast Carcinoma

Tumor Suppressor NDRG 2 Tips the Balance of Oncogenic TGF-β Via EMT Inhibition in Colorectal Cancer

Overexpression of N-Myc Downstream-Regulated Gene 2 (NDRG2) Regulates the Proliferation and Invasion of Bladder Cancer Cells in Vitro and in Vivo

NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states

Suppression of N-Myc Downstream-Regulated Gene 2 is Associated with Induction of Myc in Colorectal Cancer and Correlates Closely with Differentiation

EXPRESSION OF NDRG 2 IN COLORECTAL CARCINOMAS AND ITS CLINICAL SIGNIFICANCE

Expression of NDRG2 in human lung cancer and its correlation with prognosis

Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma

GGNBP2 Suppresses the Proliferation, Invasion, and Migration of Human Glioma Cells.